Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Roger

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|May 1, 1997
Reducing the incidence of Pneumocystis carinii pneumonia: a persisting challengeC Pradier, A Pesce, B Taillan, et al.
Medecine Et Maladies Infectieuses|August 30, 2014
The impact of bacteremia on the outcome of bone infectionsP-M Roger, E Cua, J Courjon, et al.
International Journal of Antimicrobial Agents|October 24, 2001
How to organise antibiotic prescriptionP Dellamonica, P M Roger, A Mousnier, et al.
Presse Medicale (Paris, France : 1983)|April 17, 1993
[Treatment of akinetic mutism with bromocriptine]D Milhaud, G Bernardin, P M Roger, et al.
La Revue De Medecine Interne|February 28, 2002
[Differential diagnosis of systemic vasculitis: malignant rickettsiosis]H Hyvernat, P M Roger, O Brocq, et al.
Infectious Diseases Now|February 17, 2022
Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab useR Ouissa, C Le Guillou, M Broudic, et al.
Presse Medicale (Paris, France : 1983)|November 24, 1999
[Invasive pulmonary aspergillosis during influenza: a fortuitous association?]F Vandenbos, V Mondain-Miton, P M Roger, et al.
The Journal of Infectious Diseases|January 1, 1989
Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virusE Bernard, P M Roger, D Carles, et al.
AIDS (London, England)|November 14, 1998
Do viral load and CD8 cell count at initiation of tritherapy influence the increase of CD4 T-cell count?O Keita-Perse, P M Roger, C Pradier, et al.
Presse Medicale (Paris, France : 1983)|December 21, 1996
[Hyperkalemia under treatment with high-dose trimethoprim-sulfamethoxazole]R Fouché, G Bernardin, P M Roger, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|May 1, 1997
Reducing the incidence of Pneumocystis carinii pneumonia: a persisting challengeC Pradier, A Pesce, B Taillan, et al.
Medecine Et Maladies Infectieuses|August 30, 2014
The impact of bacteremia on the outcome of bone infectionsP-M Roger, E Cua, J Courjon, et al.
International Journal of Antimicrobial Agents|October 24, 2001
How to organise antibiotic prescriptionP Dellamonica, P M Roger, A Mousnier, et al.
Presse Medicale (Paris, France : 1983)|April 17, 1993
[Treatment of akinetic mutism with bromocriptine]D Milhaud, G Bernardin, P M Roger, et al.
La Revue De Medecine Interne|February 28, 2002
[Differential diagnosis of systemic vasculitis: malignant rickettsiosis]H Hyvernat, P M Roger, O Brocq, et al.
Infectious Diseases Now|February 17, 2022
Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab useR Ouissa, C Le Guillou, M Broudic, et al.
Presse Medicale (Paris, France : 1983)|November 24, 1999
[Invasive pulmonary aspergillosis during influenza: a fortuitous association?]F Vandenbos, V Mondain-Miton, P M Roger, et al.
The Journal of Infectious Diseases|January 1, 1989
Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virusE Bernard, P M Roger, D Carles, et al.
AIDS (London, England)|November 14, 1998
Do viral load and CD8 cell count at initiation of tritherapy influence the increase of CD4 T-cell count?O Keita-Perse, P M Roger, C Pradier, et al.
Presse Medicale (Paris, France : 1983)|December 21, 1996
[Hyperkalemia under treatment with high-dose trimethoprim-sulfamethoxazole]R Fouché, G Bernardin, P M Roger, et al.
Pageof 11